Efficacy and safety of zidovudine and zalcitabine combined with a combination of herbs in the treatment of HIV-infected Thai patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 3, 2005, Pages 704-708

  Sangkitporn, Somchai ^a   Shide, Luo ^g   Klinbuayaem, Virat ^b   Leenasirimakul, Prattana ^c   Wirayutwatthana, Nuan Anong ^d   Leechanachai, Pranee ^e   Dettrairat, Sakchai ^e   Kunachiwa, Warunee ^e   Thamlikitkul, Visanu ^f  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Sanpatong Hospital   (Thailand)

^c Nakhonping Hospital   (Thailand)

^d Lamphun Hospital   (Thailand)

^e CHIANG MAI UNIVERSITY   (Thailand)

^f MAHIDOL UNIVERSITY   (Thailand)

^g KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24944537971     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chavalittumrong P, Chivapat S, Chuthaputti A, Rattanacharasroj S, Punyamong S, Butraporn R. Subacute toxicity of SH drug in rats. Medicinal Herb Research Institute Report, Department of Medical Sciences, Ministry of Public Health, Thailand, 2000.
2. Chen JJ, Luo SD, Wang YF, Zheng YT. The collection of active compounds of anti-HIV/AIDS. Kunming: Yunnan Science and Technology Publishing House, 2002: 114, 118.
3. Collier AC, Coombs RW, Schoenfeld, DA, et al. Treatment of human immunodeficiency virus infection with Saquinavir, Zidovudine, and Zalcitabine. N Engl J Med 1996; 334: 1011-8.
4. Delta Coordinating Committee and Delta Virology Committee. HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study. AIDS 1999; 13: 57-65.
5. Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 2001; 334: 824-31.
6. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996; 335: 1081-90.
7. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996; 335: 1091-8.
8. Luo SD, Fan DQ, Wang HY, Ning BM. Research on anti-HIV/AIDS activity of Chinese medicinal plants. Kunming: Yunnan Science and Technology Publishing House, 1998: 35-6, 144-5, 178-9.
9. Miyoshi I, Ohtsuki Y, Fujishita M, Yoshimoto S, Kubonishi I, Minezawa M. Detection of type C virus particles in Japanese monkeys seropositive to adult T-cell leukemia-associated antigens. Gann 1982; 73: 848-9.
10. Tang W, Eisenbrand G. Chinese drugs of plant origin. Berlin, Heidelberg: Springer-Verlag. 1992.
11. The Thai Working Group on Burden of Disease and Injuries. Burden of disease and injuries in Thailand. Priority setting for policy. Bangkok: Printing House of the War Veterans Organization of Thailand, 2002.